(Total Views: 702)
Posted On: 10/28/2020 5:49:15 PM
Post# of 145249
![Avatar](https://investorshangout.com/images/ProfileImages/573000060_60093_FD245EF6-37BD-4C88-9356-29519D0376AD.jpeg)
Re: Riztheinvestor #63594
Leronlimab still appears to be most effective in the S/C population. The limited data in this PR doesn’t list a reduction in hospitalizations, ventilations, or mortality in relation to the administration of their medication. The PR says hospital visits were reduced. So, IMO, based on the PR, leronlimab still serves a purpose in the S/C population.
I’ll say this thought, Regeneron’s cocktail appears to be a game changer when compared to remdesevir.
I’ll say this thought, Regeneron’s cocktail appears to be a game changer when compared to remdesevir.
![](/m/images/thumb-up.png)
![](/m/images/thumb-down.png)